| |
| Issue |
Title |
| |
| No 9 (2025) |
Clinical case of integrating tezepelumab in the treatment of non-T2 severe bronchial asthma |
Abstract
PDF (Rus)
|
|
V. V. Gaynitdinova, Z. M. Merzhoeva, G. S. Nuralieva, E. S. Sokolova, T. U. Bogatyreva, A. E. Shmidt, S. N. Avdeev |
| |
| No 9 (2025) |
Obstructive sleep apnea in combination with bronchial asthma and chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
|
I. Yu. Mukatova, A. S. Belevskiy, A. S. Serikova, G. S. Nuralieva, S. N. Avdeev |
| |
| No 9 (2025) |
Effectiveness of personalised medical rehabilitation programs in children with bronchial asthma |
Abstract
PDF (Rus)
|
|
A. V. Ponomareva, S. A. Barysheva, L. A. Marchenkova, M. Yu. Yakovlev, I. A. Grishechkina, N. F. Tumanova-Ponomarеva, I. G. Shiman |
| |
| No 9 (2025) |
The quality of life indicators in patients with chronic obstructive pulmonary disease after PCV vaccination: A posteriori analysis of 10-year follow-up |
Abstract
PDF (Rus)
|
|
G. L. Ignatova, S. N. Avdeev, V. N. Antonov, E. V. Blinova |
| |
| No 9 (2025) |
Influence of antidiabetic drugs on the course of bronchial asthma |
Abstract
PDF (Rus)
|
|
V. V. Salukhov, M. A. Kharitonov, Yu. V. Rudakov, A. V. Nikolaev, A. A. Chugunov, K. M. Ryazanova |
| |
| No 9 (2025) |
In search of digital approaches and application of artificial intelligence in the study, diagnosis, and treatment of sarcoidosis |
Abstract
PDF (Rus)
|
|
A. A. Vizel, S. N. Avdeev, S. G. Lebedev, I. Yu. Vizel, L. A. Vizel |
| |
| No 9 (2025) |
Etiology, pathogenesis and diagnosis of chronic obstructive pulmonary disease: Assessment of the knowledge of doctors and senior students. Results of the ASCO-III study |
Abstract
PDF (Rus)
|
|
R. A. Bontsevich, G. I. Zavitkevich, G. A. Batishcheva, V. A. Nevzorova, O. V. Tsygankova, G. G. Ketova, I. M. Martynenko, I. F. Krotkova, E. Yu. Ebzeeva, G. M. Bikkinina, I. K. Suvanov, E. A. Shabanov, G. G. Prozorova, U. M. Tilekeeva, O. G. Kompaniets, E. N. Bochanova, E. V. Luchinina, M. L. Maximov |
| |
| No 9 (2025) |
Prognostic molecular markers of the biological therapy effectiveness for severe bronchial asthma |
Abstract
PDF (Rus)
|
|
O. N. Titova, N. A. Kuzubova, E. S. Lebedeva |
| |
| No 9 (2025) |
Biological therapy of severe bronchial asthma in children: Indications and effectiveness criteria |
Abstract
PDF (Rus)
|
|
S. N. Buynova, V. M. Shinkareva, I. N. Trofimenko |
| |
| No 20 (2024) |
De-escalation of therapy in a patient with chronic obstructive pulmonary disease: A clinical observation |
Abstract
PDF (Rus)
|
|
E. V. Bolotova, A. V. Dudnikova, L. V. Shulzhenko |
| |
| No 20 (2024) |
Evaluation of the spectrum of sensitization in children with bronchial asthma in Moscow and Moscow region |
Abstract
PDF (Rus)
|
|
N. G. Kolosova, A. R. Denisova, V. D. Denisova |
| |
| No 20 (2024) |
Lung damage associated with e-cigarette smoking (EVALI) |
Abstract
PDF (Rus)
|
|
G. E. Baimakanova, I. Yu. Tarakanova, M. V. Samsonova, I. P. Beloglazova, I. V. Kaneeva, E. N. Chernikova, O. V. Manchenko, D. A. Tsiukalo |
| |
| No 20 (2024) |
Effectiveness of anti-IL-5Rα-therapy in patients with T2-inflammatory airway diseases in real clinical practice |
Abstract
PDF (Rus)
|
|
V. V. Naumova, E. К. Beltyukov, K. A. Zykov, О. P. Kovtun, T. S. Lepeshkova, O. G. Smolenskaya, G. A. Bykova, V. I. Troshina, A. N. Mineeva |
| |
| No 20 (2024) |
Targeted therapy for severe bronchial asthma: Phenotyping of patients and algorithm for selecting a genetically engineered biological drug |
Abstract
PDF (Rus)
|
|
V. V. Naumova, K. A. Zykov, R. Valenta, O. P. Kovtun, E. K. Beltyukov, О. S. Smolenskaya, G. A. Bykova, A. A. Shtanova |
| |
| No 20 (2024) |
Targeted therapy as a new perspective in the treatment of COPD |
Abstract
PDF (Rus)
|
|
N. V. Trushenko, B. B. Lavginova, O. S. Belkina, S. N. Avdeev |
| |
| No 20 (2024) |
Triple fixed combination for asthma patients |
Abstract
PDF (Rus)
|
|
I. V. Demko, E. A. Sobko, A. Yu. Kraposhina |
| |
| No 20 (2024) |
Respiratory support and oxygen therapy at home: Clinical results of the prospective observatory study |
Abstract
PDF (Rus)
|
|
S. N. Avdeev, D. N. Nevzorova, G. E. Ivanova, G. S. Lebedev, N. A. Suponeva, M. V. Avxentyeva, R. I. Shaburov, E. S. Larin, A. N. Komarov, G. N. Levitsky, S. E. Nazarov, Z. M. Merzhoeva, N. A. Karchevskaya, A. V. Morev, V. A. Movsisyan, A. S. Vasilyeva, Kh. S. Delmaeva, A. O. Bykov, B. E. Pervozvanskiy, V. V. Tkachenko, K. A. Krokhin, G. S. Nuralieva |
| |
| No 20 (2024) |
Long-term oxygen treatment in chronic respiratory failure |
Abstract
PDF (Rus)
|
|
G. S. Nuralieva, A. E. Shmidt, I. S. Avdeev, G. V. Nekludova |
| |
| No 20 (2024) |
Stability of severe asthma phenotypes |
Abstract
PDF (Rus)
|
|
G. R. Sergeeva, A. V. Emelyanov |
| |
| No 20 (2024) |
Severe asthma phenotypes and endotypes |
Abstract
PDF (Rus)
|
|
G. R. Sergeeva, A. V. Emelyanov |
| |
| No 9 (2024) |
The effectiveness of long-term respiratory support in a patient after pneumonectomy |
Abstract
PDF (Rus)
|
|
I. Yu. Mukatova, A. S. Serikova, G. S. Nuralieva, S. N. Avdeev |
| |
| No 9 (2024) |
The importance of oncological alertness in the differential diagnosis of inflammatory changes in the lungsdetected as a result of differential diagnosis of pneumonia |
Abstract
PDF (Rus)
|
|
M. F. Petrukhnova, O. O. Voronkova, O. E. Buyanova, O. N. Antyufeeva, A. E. Kamalova, M. V. Kozhevnikova, I. S. Ilgisonis, Yu. N. Belenkov |
| |
| No 9 (2024) |
Chronic adenoiditis and its effect on the reactivity of the bronchopulmonary system, the possibility of non-drug correction |
Abstract
PDF (Rus)
|
|
A. M. Korkmazov, A. V. Solodovnik, N. V. Kornova, L. S. Krasheninnikova |
| |
| No 9 (2024) |
Clinical and allergological characteristics of patients with severe bronchial asthma in the regional registry and phenotyping principles for the targeted therapy choice |
Abstract
PDF (Rus)
|
|
V. V. Naumova, E. K. Beltyukov, O. P. Kovtun, O. G. Smolenskaya, G. A. Bykova, E. S. Klyachina |
| |
| No 9 (2024) |
The effect of targeted therapy on the quality of life of patients with polypous rhinosinusitis and comorbid bronchial asthma |
Abstract
PDF (Rus)
|
|
A. M. Korkmazov, M. A. Lengina, M. Yu. Korkmazov, N. V. Kornova |
| |
| No 9 (2024) |
Use of inhaled solution of hypertonic saline combined with high-molecular-weight hyaluronic acid in patients with lower respiratory tract diseases |
Abstract
PDF (Rus)
|
|
S. N. Avdeev, S. Yu. Chikina, E. I. Kondrateva, S. A. Krasovskiy, I. V. Leshchenko, G. L. Ignatova, V. N. Antonov, A. A. Zaitsev, Z. M. Merzhoeva, I. V. Demko, L. M. Kudelya, M. F. Kinyaykin, R. H. Zulkarneev, L. V. Shulzhenko, I. N. Trofimenko, I. V. Zaikova-Khelimskaia |
| |
| No 9 (2024) |
Direct comparative study of anti-IgE and anti-IL4Rα therapy effectiveness in patients with severe allergic and mixed bronchial asthma |
Abstract
PDF (Rus)
|
|
V. V. Naumova, E. К. Beltyukov, О. P. Kovtun, G. A. Bykova, V. I. Troshina, A. N. Mineeva |
| |
| No 9 (2024) |
Age-related features of the choice of inhalers in chilren and adolescents with bronchial asthma and other respiratory diseases |
Abstract
PDF (Rus)
|
|
E. G. Furman, E. A. Khuzina |
| |
| No 9 (2024) |
Clinical case of indacaterol / glycopyrronium bromide prescription in a patient with severe copd and concomitant pathology |
Abstract
PDF (Rus)
|
|
G. I. Ignatova, V. N. Antonov, I. A. Zakharova |
| |
| No 9 (2024) |
Triple fixed drug combination in the treatment of patients with chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
|
I. V. Demko, E. A. Sobko, A. Yu. Kraposhina |
| |
| No 9 (2024) |
The role of anti-IgE therapy in achieving remission of bronchial asthma |
Abstract
PDF (Rus)
|
|
N. V. Trushenko, B. B. Lavginova, V. A. Stener, S. N. Avdeev |
| |
| No 9 (2024) |
What has antifibrotic therapy changed for patients with idiopathic pulmonary fibrosis |
Abstract
PDF (Rus)
|
|
N. A. Kuzubova, O. N. Titova, D. B. Skliarova, V. A. Volchkov |
| |
| No 9 (2024) |
A case of asthmatic granulomatosis |
Abstract
PDF (Rus)
|
|
S. N. Avdeev, V. V. Gaynitdinova, Z. M. Merzhoeva, G. S. Nuralieva, L. Yu. Nikitina, Z. G.-M. Berikkhanov |
| |
| No 20 (2023) |
Experience of using omalizumab in patients with severe bronchial asthma |
Abstract
PDF (Rus)
|
|
E. V. Bolotova, A. V. Dudnikova, L. V. Shulzhenko |
| |
| No 20 (2023) |
Role of surfactant in the pathogenesis of bronchopulmonary pathology |
Abstract
PDF (Rus)
|
|
M. A. Kharitonov, Yu. V. Rudakov, V. V. Salukhov, N. I. Voloshin |
| |
| No 20 (2023) |
Omalizumab: a quarter of a century in the fight against T2-inflammatory diseases of upper and lower respiratory tract |
Abstract
PDF (Rus)
|
|
V. V. Naumova, E. K. Beltyukov, D. V. Kiseleva, A. A. Shtanova, D. A. Stepina |
| |
| No 20 (2023) |
The role of peak inspiratory flow in the selection of inhalation therapy in patients with chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
|
N. V. Trushenko, B. B. Lavginova, N. E. Obukhova, K. A. Brynza, G. S. Nuralieva, G. V. Nekludova, A. I. Avdeeva, S. N. Avdeev |
| |
| No 20 (2023) |
Combined therapy of broncho-obstructive pathology: two solutions to one problem |
Abstract
PDF (Rus)
|
|
A. A. Vizel, I. Yu. Vizel |
| |
| No 20 (2023) |
Vaccination as a tool for influencing the course of chronic obstructive pulmonary disease in patients with diabetes mellitus |
Abstract
PDF (Rus)
|
|
G. L. Ignatova, E. V. Blinova, V. N. Antonov |
| |
| No 20 (2023) |
Clinical efficacy of a triple combination of budesonide/ glycopyrronium bromide/formoterol in the treatment of chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
|
N. V. Trushenko, B. B. Lavginova, G. S. Nuralieva, S. N. Avdeev |
| |
| No 20 (2023) |
Direct comparative study of the effectiveness of mepolizumab and dupilumab in patients with severe non-allergic eosinophilic asthma |
Abstract
PDF (Rus)
PDF (Eng)
|
|
V. V. Naumova, E. K. Beltyukov, O. P. Kovtun, G. A. Bykova, O. G. Smolenskaya, A. A. Shtanova, D. A. Stepina |
| |
| No 4 (2023) |
The role of microRNA in the pathogenesis of bronchoobstructive diseases |
Abstract
PDF (Rus)
|
|
I. V. Demko, E. A. Sobko, A. Yu. Kraposhina, A. B. Katser, K. I. Shadrina, O. V. Kazmerchuk, Yu. I. Abramov, S. A. Geyl, Yu. A. Khramova |
| |
| No 4 (2023) |
Obesity – hypoventilation syndrome |
Abstract
PDF (Rus)
|
|
G. S. Nuralieva, M. V. Bodunkov, K. I. Bikbauv, E. A. Samoilov, N. A. Tsareva, N. V. Trushenko, S. N. Avdeev |
| |
| No 4 (2023) |
Experience with the use of immunobiological drugs in the treatment of patients with severe bronchial asthma and comorbidities |
Abstract
PDF (Rus)
|
|
V. P. Sereda, D. A. Svirido, M. V. Komarov, O. A. Smulskaya |
| |
| No 4 (2023) |
Efficacy of two-year anti-IgE therapy in patients with severe allergic bronchial asthma in Sverdlovsk region |
Abstract
PDF (Rus)
|
|
V. V. Naumova, Е. К. Beltyukov, V. Ch. Abdullaev, A. U. Petukhova, A. A. Shtanova, D. A. Stepina |
| |
| No 18 (2022) |
Сlinical and allergological characteristics of chronic inflammatory diseases of the nose in patients with severe bronchial asthma receiving immunobiological therapy in the Sverdlovsk region |
Abstract
PDF (Rus)
|
|
D. V. Kiseleva, E. K. Beltyukov, V. V. Naumova |
| |
| No 18 (2022) |
New options for severe asthma |
Abstract
PDF (Rus)
|
|
A. Yu. Kraposhina, E. A. Sobko, I. V. Demko, A. B. Katser, O. V. Kazmerchuk, Yu. I. Abramov, S. V. Chubarova |
| |
| No 18 (2022) |
Clinical and molecular features of virus-induced acute exacerbations of chronic obstructive pulmonary diseas |
Abstract
PDF (Rus)
|
|
L. A. Shpagina, O. S. Kotova, I. S. Shpagin, D. A. Gerasimenko, G. V. Kuznetsova, S. A. Karmanovskaya, E. M. Loktin, A. A. Rukavitsyna, E. V. Anikina, N. V. Kamneva, K. V. Likhenko-Logvinenko |
| |
| No 18 (2022) |
Bronchial asthma: focus on adherence to inhaled therapy |
Abstract
PDF (Rus)
|
|
O. V. Fesenko |
| |
| No 18 (2022) |
Double broncholytic combination of umeclidnium/ vilanterol in COPD therapy: issues of efficacy and safety |
Abstract
PDF (Rus)
|
|
N. P. Knyazheskaya, E. Кh. Anaev, A. S. Belevskiy, M. A. Makarova |
| |
| 1 - 50 of 50 Items |
|
